ANI Pharmaceuticals Inc. (ANIP)

59.97
NASDAQ : Health Technology
Prev Close 60.64
Day Low/High 59.04 / 60.30
52 Wk Low/High 42.23 / 74.70
Avg Volume 123.20K
Exchange NASDAQ
Shares Outstanding 11.64M
Market Cap 706.39M
EPS -0.10
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

3 Biotech Stocks I Love for March (Celgene Is One of Them)

3 Biotech Stocks I Love for March (Celgene Is One of Them)

These biotech names are all great buys on dips. Notably Celgene, which is fresh off a terrible trading session.

3 Promising Biotech Stocks to Buy on Dips

3 Promising Biotech Stocks to Buy on Dips

From ANI Pharmaceuticals to T2 Biosystems, these names look good.

Three Biotech Opportunities

Three Biotech Opportunities

Celgene, ANI and T2 are seeing attractive entry points.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: CXO, GOGL, LBRDA, LBRDK Downgrades: ANIP, CTB, HVT, HVT.A, MANH, MDT, MSA, PMBC, TAYD, TGH, UBP Initiations: CJ, FTI, VREX Read on to get TheStreet Quant Ratings' detailed report:

Commit To Purchase ANI Pharmaceuticals At $35, Earn 18.7% Annualized Using Options

Commit To Purchase ANI Pharmaceuticals At $35, Earn 18.7% Annualized Using Options

Investors eyeing a purchase of ANI Pharmaceuticals Inc shares, but tentative about paying the going market price of $60.79/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the March put at the $35 strike, which has a bid at the time of this writing of 70 cents.

ANI Pharmaceuticals Reaches Analyst Target Price

ANI Pharmaceuticals Reaches Analyst Target Price

In recent trading, shares of ANI Pharmaceuticals Inc have crossed above the average analyst 12-month target price of $66.33, changing hands for $68.73/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

ANIP Crosses Above Average Analyst Target

ANIP Crosses Above Average Analyst Target

In recent trading, shares of ANI Pharmaceuticals Inc have crossed above the average analyst 12-month target price of $66.33, changing hands for $74.56/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AINV, AMOT, ANIP, EXFO, EXPR, INBK, LIND, LNN, LTM, MJCO, MYRG, SGEN, WEYS Downgrades: BAM, ESRT, IAG, PGRE, RRTS, SSRM Initiations: RARE Read on to get TheStreet Quant Ratings' detailed report:

3 Small-Caps on My Growth Stock Radar

3 Small-Caps on My Growth Stock Radar

LGI Homes, ANI Pharmaceuticals and Sonus Networks are worth considering.

ANI Pharmaceuticals Breaks Above 200-Day Moving Average - Bullish for ANIP

ANI Pharmaceuticals Breaks Above 200-Day Moving Average - Bullish for ANIP

In trading on Wednesday, shares of ANI Pharmaceuticals Inc crossed above their 200 day moving average of $51.40, changing hands as high as $51.80 per share. ANI Pharmaceuticals Inc shares are currently trading up about 3.3% on the day.

Commit To Buy ANI Pharmaceuticals At $30, Earn 10.1% Annualized Using Options

Commit To Buy ANI Pharmaceuticals At $30, Earn 10.1% Annualized Using Options

Investors considering a purchase of ANI Pharmaceuticals Inc stock, but cautious about paying the going market price of $50.73/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2018 put at the $30 strike, which has a bid at the time of this writing of $1.00.

ANI Pharmaceuticals Enters Oversold Territory (ANIP)

ANI Pharmaceuticals Enters Oversold Territory (ANIP)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Commit To Purchase ANI Pharmaceuticals At $35, Earn 8.6% Annualized Using Options

Investors eyeing a purchase of ANI Pharmaceuticals Inc stock, but tentative about paying the going market price of $43.97/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2018 put at the $35 strike, which has a bid at the time of this writing of $1.85.

Oversold Conditions For ANI Pharmaceuticals (ANIP)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Bearish Bets: A Drug Maker, a Boutique Retailer and Other Stocks That Look Good Short

MBI, CMP, FRAN, ANIP and PHX all recently were downgraded by TheStreet's Quant Ratings.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ABDC, BCBP, CERN, DVA, EDGW, GRUB, INS, LRN, MET, NC, NEWS, OAK Downgrades: ANIP, BBSI, CVG, FRAN, FTD, MHLD, PHX Initiations: NVTR, SNDX Read on to get TheStreet Quant Ratings' detailed report:

Commit To Purchase ANI Pharmaceuticals At $35, Earn 7.9% Annualized Using Options

Investors considering a purchase of ANI Pharmaceuticals Inc shares, but cautious about paying the going market price of $49.91/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the October put at the $35 strike, which has a bid at the time of this writing of $1.70.

ANI Pharmaceuticals Breaks Below 200-Day Moving Average - Notable for ANIP

In trading on Wednesday, shares of ANI Pharmaceuticals Inc crossed below their 200 day moving average of $59.71, changing hands as low as $59.61 per share. ANI Pharmaceuticals Inc shares are currently trading off about 5.4% on the day.

Notable Two Hundred Day Moving Average Cross - ANIP

Notable Two Hundred Day Moving Average Cross - ANIP

In trading on Thursday, shares of ANI Pharmaceuticals Inc crossed below their 200 day moving average of $57.58, changing hands as low as $57.03 per share. ANI Pharmaceuticals Inc shares are currently trading down about 2% on the day.

5 Stocks Poised for Major Breakouts

5 Stocks Poised for Major Breakouts

These stocks are within range of triggering breakout trades. Here's how to trade them from here.

ANI Pharmaceuticals (ANIP) Shares Cross Below 200 DMA

ANI Pharmaceuticals (ANIP) Shares Cross Below 200 DMA

In trading on Thursday, shares of ANI Pharmaceuticals Inc crossed below their 200 day moving average of $51.16, changing hands as low as $47.25 per share. ANI Pharmaceuticals Inc shares are currently trading off about 23.4% on the day.

Oversold Conditions For ANI Pharmaceuticals (ANIP)

Oversold Conditions For ANI Pharmaceuticals (ANIP)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

ANI Pharmaceuticals' Varied Offerings, Strategic Acquisitions Make It a Good Play for Investors

ANI Pharmaceuticals' Varied Offerings, Strategic Acquisitions Make It a Good Play for Investors

The Baudette, Minn.-based company has 79 products generating about $4 billion in sales and a number of other promising therapies in its pipeline.

TheStreet Quant Rating: C- (Hold)